Table of Contents

1 Study Coverage

• 1.1 Antifungal Agents Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Antifungal Agents Market Size Growth Rate by Product
  • 1.4.2 Aspergillosis
  • 1.4.3 Dermatophytosis
  • 1.4.4 Candidiasis
  • 1.4.5 Others
• 1.5 Market by End User
  • 1.5.1 Global Antifungal Agents Market Size Growth Rate by End User
  • 1.5.2 Powders
  • 1.5.3 Ointments
  • 1.5.4 Drugs
  • 1.5.5 Pastes
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Antifungal Agents Market Size
  • 2.1.1 Global Antifungal Agents Revenue 2014-2025
  • 2.1.2 Global Antifungal Agents Sales 2014-2025
• 2.2 Antifungal Agents Growth Rate by Regions
  • 2.2.1 Global Antifungal Agents Sales by Regions
  • 2.2.2 Global Antifungal Agents Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Antifungal Agents Sales by Manufacturers
  • 3.1.1 Antifungal Agents Sales by Manufacturers
  • 3.1.2 Antifungal Agents Sales Market Share by Manufacturers
  • 3.1.3 Global Antifungal Agents Market Concentration Ratio (CR5 and HHI)
• 3.2 Antifungal Agents Revenue by Manufacturers
  • 3.2.1 Antifungal Agents Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antifungal Agents Revenue Share by Manufacturers (2014-2019)
• 3.3 Antifungal Agents Price by Manufacturers
• 3.4 Antifungal Agents Manufacturing Base Distribution, Product Types
  • 3.4.1 Antifungal Agents Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Antifungal Agents Product Type
  • 3.4.3 Date of International Manufacturers Enter into Antifungal Agents Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Antifungal Agents Sales by Product
• 4.2 Global Antifungal Agents Revenue by Product
• 4.3 Antifungal Agents Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Antifungal Agents Breakdown Data by End User

6 North America

• 6.1 North America Antifungal Agents by Countries
  • 6.1.1 North America Antifungal Agents Sales by Countries
  • 6.1.2 North America Antifungal Agents Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Antifungal Agents by Product
• 6.3 North America Antifungal Agents by End User

7 Europe

• 7.1 Europe Antifungal Agents by Countries
  • 7.1.1 Europe Antifungal Agents Sales by Countries
  • 7.1.2 Europe Antifungal Agents Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Antifungal Agents by Product
• 7.3 Europe Antifungal Agents by End User

8 Asia Pacific

• 8.1 Asia Pacific Antifungal Agents by Countries
  • 8.1.1 Asia Pacific Antifungal Agents Sales by Countries
  • 8.1.2 Asia Pacific Antifungal Agents Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Antifungal Agents by Product
• 8.3 Asia Pacific Antifungal Agents by End User

9 Central & South America

• 9.1 Central & South America Antifungal Agents by Countries
  • 9.1.1 Central & South America Antifungal Agents Sales by Countries
  • 9.1.2 Central & South America Antifungal Agents Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Antifungal Agents by Product
• 9.3 Central & South America Antifungal Agents by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Antifungal Agents by Countries
  • 10.1.1 Middle East and Africa Antifungal Agents Sales by Countries
  • 10.1.2 Middle East and Africa Antifungal Agents Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Antifungal Agents by Product
• 10.3 Middle East and Africa Antifungal Agents by End User

11 Company Profiles

• 11.1 Asperqillus
  • 11.1.1 Asperqillus Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Asperqillus Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Asperqillus Antifungal Agents Products Offered
  • 11.1.5 Asperqillus Recent Development
• 11.2 Alternaria
  • 11.2.1 Alternaria Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Alternaria Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Alternaria Antifungal Agents Products Offered
  • 11.2.5 Alternaria Recent Development
• 11.3 Abbott
  • 11.3.1 Abbott Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Abbott Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Abbott Antifungal Agents Products Offered
  • 11.3.5 Abbott Recent Development
• 11.4 Pfizer
  • 11.4.1 Pfizer Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Pfizer Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Pfizer Antifungal Agents Products Offered
  • 11.4.5 Pfizer Recent Development
• 11.5 Glaxosmithkline
  • 11.5.1 Glaxosmithkline Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Glaxosmithkline Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Glaxosmithkline Antifungal Agents Products Offered
  • 11.5.5 Glaxosmithkline Recent Development
• 11.6 Bayer
  • 11.6.1 Bayer Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Bayer Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Bayer Antifungal Agents Products Offered
  • 11.6.5 Bayer Recent Development
• 11.7 Novartis
  • 11.7.1 Novartis Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Novartis Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Novartis Antifungal Agents Products Offered
  • 11.7.5 Novartis Recent Development
• 11.8 Sanofi-Aventis
  • 11.8.1 Sanofi-Aventis Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Sanofi-Aventis Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Sanofi-Aventis Antifungal Agents Products Offered
  • 11.8.5 Sanofi-Aventis Recent Development
• 11.9 Merck
  • 11.9.1 Merck Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Merck Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Merck Antifungal Agents Products Offered
  • 11.9.5 Merck Recent Development
• 11.10 Kramer
  • 11.10.1 Kramer Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Kramer Antifungal Agents Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Kramer Antifungal Agents Products Offered
  • 11.10.5 Kramer Recent Development
• 11.11 Enzon
• 11.12 Gilead

12 Future Forecast

• 12.1 Antifungal Agents Market Forecast by Regions
  • 12.1.1 Global Antifungal Agents Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Antifungal Agents Revenue Forecast by Regions 2019-2025
• 12.2 Antifungal Agents Market Forecast by Product
  • 12.2.1 Global Antifungal Agents Sales Forecast by Product 2019-2025
  • 12.2.2 Global Antifungal Agents Revenue Forecast by Product 2019-2025
• 12.3 Antifungal Agents Market Forecast by End User
• 12.4 North America Antifungal Agents Forecast
• 12.5 Europe Antifungal Agents Forecast
• 12.6 Asia Pacific Antifungal Agents Forecast
• 12.7 Central & South America Antifungal Agents Forecast
• 12.8 Middle East and Africa Antifungal Agents Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Antifungal Agents Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Anti fungal agent is a drug that detects and eliminates fungal pathogens from foreign body with minimal toxic side effects to the body.
The global Antifungal Agents market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antifungal Agents market based on company, product type, end user and key regions.

This report studies the global market size of Antifungal Agents in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antifungal Agents in these regions.
This research report categorizes the global Antifungal Agents market by top players/brands, region, type and end user. This report also studies the global Antifungal Agents market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Asperqillus
Alternaria
Abbott
Pfizer
Glaxosmithkline
Bayer
Novartis
Sanofi-Aventis
Merck
Kramer
Enzon
Gilead

Market size by Product
By theraprtutic indications
Aspergillosis
Dermatophytosis
Candidiasis
Others
By drug type
Echinocandins
Azoles
Ployenes
Allylamines
Others
By audience
Pharmaceutical companies
Government and private research institutes
Academic Institutes
Suppliers and distributors
Market size by End User
Powders
Ointments
Drugs
Pastes

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Antifungal Agents market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antifungal Agents market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antifungal Agents companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antifungal Agents submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Antifungal Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antifungal Agents market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.